786 related articles for article (PubMed ID: 25633908)
1. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation.
Crossan C; Tsochatzis EA; Longworth L; Gurusamy K; Davidson B; Rodríguez-Perálvarez M; Mantzoukis K; O'Brien J; Thalassinos E; Papastergiou V; Burroughs A
Health Technol Assess; 2015 Jan; 19(9):1-409, v-vi. PubMed ID: 25633908
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.
Stevenson M; Lloyd-Jones M; Morgan MY; Wong R
Health Technol Assess; 2012; 16(4):1-174. PubMed ID: 22333291
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation.
Bresnahan R; Duarte R; Mahon J; Beale S; Chaplin M; Bhattacharyya D; Houten R; Edwards K; Nevitt S; Maden M; Boland A
Health Technol Assess; 2023 Jul; 27(10):1-115. PubMed ID: 37839810
[TBL] [Abstract][Full Text] [Related]
4. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis B in the UK: systematic review and economic evaluation.
Crossan C; Tsochatzis EA; Longworth L; Gurusamy K; Papastergiou V; Thalassinos E; Mantzoukis K; Rodriguez-Peralvarez M; O'Brien J; Noel-Storr A; Papatheodoridis GV; Davidson B; Burroughs AK
J Viral Hepat; 2016 Feb; 23(2):139-49. PubMed ID: 26444996
[TBL] [Abstract][Full Text] [Related]
6. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
Campbell F; Thokala P; Uttley LC; Sutton A; Sutton AJ; Al-Mohammad A; Thomas SM
Health Technol Assess; 2014 Sep; 18(59):1-120. PubMed ID: 25265259
[TBL] [Abstract][Full Text] [Related]
7. Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome.
Goodacre S; Thokala P; Carroll C; Stevens JW; Leaviss J; Al Khalaf M; Collinson P; Morris F; Evans P; Wang J
Health Technol Assess; 2013; 17(1):v-vi, 1-188. PubMed ID: 23331845
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients.
Soto M; Sampietro-Colom L; Lasalvia L; Mira A; Jiménez W; Navasa M
World J Gastroenterol; 2017 May; 23(17):3163-3173. PubMed ID: 28533673
[TBL] [Abstract][Full Text] [Related]
9. Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation.
Sharma P; Boyers D; Boachie C; Stewart F; Miedzybrodzka Z; Simpson W; Kilonzo M; McNamee P; Mowatt G
Health Technol Assess; 2012; 16(17):1-266. PubMed ID: 22469073
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C.
Tsochatzis EA; Crossan C; Longworth L; Gurusamy K; Rodriguez-Peralvarez M; Mantzoukis K; O'Brien J; Thalassinos E; Papastergiou V; Noel-Storr A; Davidson B; Burroughs AK
Hepatology; 2014 Sep; 60(3):832-43. PubMed ID: 25043847
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
[TBL] [Abstract][Full Text] [Related]
12. Transient Elastography and Controlled Attenuation Parameter for Diagnosing Liver Fibrosis and Steatosis in Ontario: An Economic Analysis.
Thavorn K; Coyle D
Ont Health Technol Assess Ser; 2015; 15(19):1-58. PubMed ID: 26664666
[TBL] [Abstract][Full Text] [Related]
13. SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis.
Riemsma R; Al M; Corro Ramos I; Deshpande SN; Armstrong N; Lee YC; Ryder S; Noake C; Krol M; Oppe M; Kleijnen J; Severens H
Health Technol Assess; 2013 Dec; 17(61):1-236. PubMed ID: 24351663
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study.
Tanajewski L; Harris R; Harman DJ; Aithal GP; Card TR; Gkountouras G; Berdunov V; Guha IN; Elliott RA
BMJ Open; 2017 Jul; 7(6):e015659. PubMed ID: 28679676
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom.
Bermingham SL; Hughes R; Fenu E; Sawyer LM; Boxall E; T Kennedy P; Dusheiko G; Hill-Cawthorne G; Thomas H
Value Health; 2015 Sep; 18(6):800-9. PubMed ID: 26409607
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of fibrosis assessment prior to treatment for chronic hepatitis C patients.
Liu S; Schwarzinger M; Carrat F; Goldhaber-Fiebert JD
PLoS One; 2011; 6(12):e26783. PubMed ID: 22164204
[TBL] [Abstract][Full Text] [Related]
17. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
Thompson Coon J; Rogers G; Hewson P; Wright D; Anderson R; Cramp M; Jackson S; Ryder S; Price A; Stein K
Health Technol Assess; 2007 Sep; 11(34):1-206. PubMed ID: 17767898
[TBL] [Abstract][Full Text] [Related]
18. Early Treatment in HCV: Is it a Cost-Utility Option from the Italian Perspective?
Marcellusi A; Viti R; Damele F; Cammà C; Taliani G; Mennini FS
Clin Drug Investig; 2016 Aug; 36(8):661-72. PubMed ID: 27234943
[TBL] [Abstract][Full Text] [Related]
19. Transient elastography for the diagnosis of liver fibrosis: a systematic review of economic evaluations.
van Katwyk S; Coyle D; Cooper C; Pussegoda K; Cameron C; Skidmore B; Brener S; Moher D; Thavorn K
Liver Int; 2017 Jun; 37(6):851-861. PubMed ID: 27699993
[TBL] [Abstract][Full Text] [Related]
20. Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreath.
Harnan SE; Tappenden P; Essat M; Gomersall T; Minton J; Wong R; Pavord I; Everard M; Lawson R
Health Technol Assess; 2015 Oct; 19(82):1-330. PubMed ID: 26484874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
